Automated Multiparameter Flow Cytometry (MFC) Immunophenotyping for Reproducible Identification of High Risk Smoldering Multiple Myeloma (SMM)

被引:0
|
作者
Paiva, Bruno [1 ]
Johnson, Sarah K. [2 ]
Mateos, Maria-Victoria [3 ]
Alapat, Daisy V. [4 ]
Puig, Noemi [5 ]
Hernandez, Miguel-T [6 ]
Escalante, Fernando [7 ]
de Coca, Alfonso Garcia [8 ]
Blade, Joan [9 ]
Lahuerta, Juan Jose [10 ]
Lecrevisse, Quentin [11 ]
van Dongen, Jacques J. M. [12 ]
Orfao, Alberto [13 ]
Morgan, Gareth J. [2 ]
Barlogie, Bart [14 ]
San Miguel, Jesus [15 ]
机构
[1] Univ Navarra, Clin Univ Navarra, Ctr Invest Med Aplicada, Pamplona, Spain
[2] Univ Arkansas Med Sci, Myeloma Inst, Little Rock, AR USA
[3] Univ Salamanca, CSIC, IBMCC, Salamanca, Spain
[4] Univ Arkansas Med Sci, Dept Pathol, Little Rock, AR USA
[5] Hosp Univ Salamanca, Dept Hematol, Salamanca, Spain
[6] Hosp Univ Canarias, Tenerife, Spain
[7] Hosp Leon, Leon, Spain
[8] Hosp Clin Univ Valladolid, Valladolid, Spain
[9] Univ Barcelona, IDIBAPS, Hosp Clin Barcelona, Servei Hematol, Barcelona, Spain
[10] Hosp 12 Octubre, Madrid, Spain
[11] Univ Salamanca, Salamanca, Spain
[12] Erasmus MC, Dept Immunol, Lab Med Immunol, Rotterdam, Netherlands
[13] Univ Salamanca, CIC, IBMCC USAL CSIC, Serv Gen Citometria, Salamanca, Spain
[14] Icahn Sch Med Mt Sinai, Hematol & Med Oncol, New York, NY USA
[15] CIMA UNAV IDISNA, Pamplona, Spain
关键词
D O I
10.1182/blood.V128.22.373.373
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
373
引用
收藏
页数:5
相关论文
共 50 条
  • [31] Minimally invasive profiling of tumor and immune cells to stratify risk in smoldering multiple myeloma (SMM): the iMMunocell study
    Termini, Rosalinda
    Botta, David Zihala Cirino
    Maia, Catarina
    Garces, Juan Jose
    Terpos, Evangelos
    Montana, Albert Perez
    Jelinek, Tomas
    Bargay, Joan
    Ocio, Enrique
    De la Puerta, Jose Enrique
    Martinez-Lopez, Joaquin
    Solano, Fernando
    Cabezudo, Maria-Elena
    Iglesias, Rebeca
    Garcia-Guinon, Antonio
    Casanova, Maria
    Cabanas, Valentin
    Hajek, Roman
    Ludwig, Heinz
    Goldschmidt, Hartmut
    Avet-Loiseau, Herve
    Roccaro, Aldo Roccaro
    San-Miguel, Jesus F.
    Paiva, Bruno
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 : S22 - S23
  • [32] Cytogenetic Risk-Stratification of Multiple Myeloma Based on the Neoplastic Plasma Cell Antigen Expression Signature By High Sensitivity Multiparameter Flow Cytometry
    Rosenblum, Frida
    Pozdnyakova, Olga
    Morgan, Elizabeth
    Li, Betty
    Charest, Karry
    Dorfman, David
    MODERN PATHOLOGY, 2015, 28 : 374A - 375A
  • [33] Cytogenic Risk-Stratification of Multiple Myeloma Based on the Neoplastic Plasma Cell Antigen Expression Signature By High Sensitivity Multiparameter Flow Cytometry
    Rosenblum, Frida
    Pozdnyakova, Olga
    Morgan, Elizabeth
    Li, Betty
    Charest, Karry
    Dorfman, David
    LABORATORY INVESTIGATION, 2015, 95 : 374A - 375A
  • [34] Lenalidomide plus Dexamethasone for High-Risk Smoldering Multiple Myeloma
    Mateos, Maria-Victoria
    Hernandez, Miguel-Teodoro
    Giraldo, Pilar
    de la Rubia, Javier
    de Arriba, Felipe
    Lopez Corral, Lucia
    Rosinol, Laura
    Paiva, Bruno
    Palomera, Luis
    Bargay, Joan
    Oriol, Albert
    Prosper, Felipe
    Lopez, Javier
    Olavarria, Eduardo
    Quintana, Nuria
    Garcia, Jose-Luis
    Blade, Joan
    Lahuerta, Juan-Jose
    San Miguel, Jesus-F.
    NEW ENGLAND JOURNAL OF MEDICINE, 2013, 369 (05): : 438 - 447
  • [35] How to Identify and Manage High-Risk Smoldering Multiple Myeloma
    Mouhieddine, Tarek H.
    CURRENT ONCOLOGY REPORTS, 2024, 26 (11) : 1398 - 1409
  • [36] Genomic profiling of treated high-risk smoldering multiple myeloma
    Diamond, Benjamin
    Kazandjian, Dickran
    Papadimitriou, Marios
    Ziccheddu, Bachisio
    Blaney, Patrick
    Chojnacka, Monika
    Durante, Michael
    Hill, Elizabeth
    Sklavenitis-Pistofidis, Romanos
    Davies, Faith
    Getz, Gad
    Ghobrial, Irene
    Morgan, Gareth
    Maura, Francesco
    Landgren, Ola
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S227 - S228
  • [38] The prognostic value of multiparameter flow cytometry minimal residual disease assessment in relapsed multiple myeloma
    Paiva, Bruno
    Chandia, Mauricio
    Puig, Noemi
    Vidriales, Maria-Belen
    Perez, Jose J.
    Lopez-Corral, Lucia
    Ocio, Enrique M.
    Garcia-Sanz, Ramon
    Gutierrez, Norma C.
    Jimenez-Ubieto, Ana
    Lahuerta, Juan-Jose
    Mateos, Maria-Victoria
    San Miguel, Jesus F.
    HAEMATOLOGICA, 2015, 100 (02) : E53 - E55
  • [39] High-Risk Cytogenetics and Persistent Minimal Residual Disease (MRD) by Multiparameter Flow Cytometry (MFC) Predict Unsustained Complete Response (CR) After Autologous Stem Cell Transplantation (ASCT) in Multiple Myeloma (MM)
    Paiva, Bruno
    Gutierrez, Norma C.
    Rosinol, Laura
    Vidriales, Maria-Belen
    Montalban, Maria-Angeles
    Martinez-Lopez, Joaquin
    Victoria Mateos, Maria
    Teresa Cibeira, Maria
    Courdon, Lourdes
    Oriol, Albert
    Jose Terol, Maria
    Echebeste, Maria-Asuncion
    de Paz, Raquel
    de Arriba, Felipe
    Palomera, Luis
    De La Rubia, Javier
    Diaz-Mediavilla, Joaquin
    Sureda, Anna
    Gorosquieta, Ana
    Alegre, Adrian
    Martin, Alejandro
    Hernandez, Miguel T.
    Jose Lahuerta, Juan
    Blade, Joan
    San Miguel, Jesus F.
    BLOOD, 2011, 118 (21) : 287 - 288
  • [40] BrdU incorporation in multiparameter flow cytometry: A new cell cycle assessment approach in multiple myeloma
    Requirand, Guilhem
    Robert, Nicolas
    Boireau, Stephanie
    Vincent, Laure
    Seckinger, Anja
    Bouhya, Salaheddine
    Ceballos, Patrice
    Cartron, Guillaume
    Hose, Dirk
    Klein, Bernard
    Moreaux, Jerome
    CYTOMETRY PART B-CLINICAL CYTOMETRY, 2019, 96 (03) : 209 - 214